Propionic Acidemia Overview

Save information for later
Sign Up

Learn About Propionic Acidemia

What is the definition of Propionic Acidemia?
Propionic acidemia is an inherited condition in which the body can't breakdown certain parts of proteins and fats. This leads to a build-up of toxic substances and to bouts of serious illness called decompensation events or metabolic crises. Symptoms of a decompensation event include poor feeding, vomiting, weak muscle tone (hypotonia), and lack of energy (lethargy). Without early diagnosis and treatment, these symptoms may lead to more serious medical problems, including heart abnormalities, seizures, intellectual disability, coma, and possibly death. Propionic acidemia is caused by changes in the PCCA and PCCB genes and is inherited in an autosomal recessive pattern. Diagnosis is based on the symptoms, clinical exam, blood and urine testing, and may be confirmed by the results of genetic testing.
What are the alternative names for Propionic Acidemia?
  • Propionic acidemia
  • Glycinemia, ketotic
  • Hyperglycinemia with ketoacidosis and leukopenia
  • Ketotic glycinemia
  • Ketotic hyperglycinemia
  • PCC deficiency
  • PROP
  • Propionicacidemia
  • Propionyl-CoA carboxylase deficiency
Who are the top Propionic Acidemia Local Doctors?
Elite in Propionic Acidemia
Dr. Charles P. Venditti
Medical Genetics
Elite in Propionic Acidemia
Dr. Charles P. Venditti
Medical Genetics
9000 Rockville Pike National Institutes Of Health, Building 49 Rm 4a18, 
Bethesda, MD 
301-496-6213
Languages Spoken:
English

Charles Venditti is a Medical Genetics provider in Bethesda, Maryland. Dr. Venditti is rated as an Elite provider by MediFind in the treatment of Propionic Acidemia. His top areas of expertise are Methylmalonic Acidemia, Propionic Acidemia, Homocystinuria, and Niemann-Pick Disease.

Elite in Propionic Acidemia
Dr. Oleg A. Shchelochkov
Medical Genetics | Pediatrics
Elite in Propionic Acidemia
Dr. Oleg A. Shchelochkov
Medical Genetics | Pediatrics
200 Hawkins Dr, 
Iowa City, IA 
319-356-4016
Languages Spoken:
English

Oleg Shchelochkov is a Medical Genetics specialist and a Pediatrics provider in Iowa City, Iowa. Dr. Shchelochkov is rated as an Elite provider by MediFind in the treatment of Propionic Acidemia. His top areas of expertise are Propionic Acidemia, Argininosuccinic Aciduria, Methylmalonic Acidemia, and Urea Cycle Disorders (UCD).

 
 
 
 
Learn about our expert tiers
Learn More
Dwight D. Koeberl
Distinguished in Propionic Acidemia
Dr. Dwight D. Koeberl
Medical Genetics | Pediatrics
Distinguished in Propionic Acidemia
Dr. Dwight D. Koeberl
Medical Genetics | Pediatrics

Duke University Hospital

2301 Erwin Rd, 
Durham, NC 
919-684-8111
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Dwight Koeberl is a Medical Genetics specialist and a Pediatrics provider in Durham, North Carolina. Dr. Koeberl is rated as a Distinguished provider by MediFind in the treatment of Propionic Acidemia. His top areas of expertise are Pompe Disease, Von Gierke Disease, X-Linked Creatine Deficiency, and Propionic Acidemia. Dr. Koeberl is currently accepting new patients.

View All Doctors
What are the latest Propionic Acidemia Clinical Trials?
The Natural History, Physiology, Microbiome and Biochemistry Studies of Propionic Acidemia
The Natural History, Physiology, Microbiome and Biochemistry Studies of Propionic Acidemia
Enrollment Status: Recruiting
Publish Date: December 02, 2025

Background: People s bodies need to break down food into the chemicals. These chemicals are used for energy and growth. Some people cannot process all chemicals very well. Too much of some chemicals can cause diseases. One of these diseases is called propionic acidemia (PA). People with PA can have problems with growth, learning heart, abdomen, and other organs. Researchers want to better understand how these...

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Global, Phase 1/2, Open-Label, Dose Optimization Study to Evaluate the Safety, Pharmacodynamics, and Pharmacokinetics of mRNA-3927 in Participants With Propionic Acidemia
A Global, Phase 1/2, Open-Label, Dose Optimization Study to Evaluate the Safety, Pharmacodynamics, and Pharmacokinetics of mRNA-3927 in Participants With Propionic Acidemia
Who is this study for: Children and adults with propionic acidemia
Enrollment Status: Recruiting
Publish Date: October 31, 2025
Intervention Type: Biological
Study Drug: mRNA-3927
Study Phase: Phase 1/Phase 2

Summary: This 3-part, Phase 1/2 study is designed to characterize the safety, tolerability, and pharmacological activity (as assessed by biomarker measurements) and to determine the selected dose of mRNA-3927 in participants with genetically confirmed propionic acidemia (PA). After establishing a dose with an acceptable safety and pharmacodynamic (PD) response for participants ≥1 year of age in Part 1, par...

View All Clinical Trials
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center